HomeSILO • NASDAQ
Silo Pharma Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 18.03K | — |
Operating expense | 1.83M | — |
Net income | -1.73M | — |
Net profit margin | -9.60K | — |
Earnings per share | — | — |
EBITDA | -1.81M | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.08M | -7.63% |
Total assets | 7.41M | -4.32% |
Total liabilities | 2.38M | 51.51% |
Total equity | 5.03M | — |
Shares outstanding | 4.48M | — |
Price to book | 0.91 | — |
Return on assets | -56.74% | — |
Return on capital | -76.73% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.73M | — |
Cash from operations | -917.43K | — |
Cash from investing | -37.66K | — |
Cash from financing | 0.00 | — |
Net change in cash | -955.09K | — |
Free cash flow | -303.76K | — |
Previous close
$1.02
Day range
$1.02 - $1.05
Year range
$0.77 - $4.46
Market cap
4.62M USD
Avg Volume
118.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2010
Headquarters
Website
Employees
3
